• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

iPSC 质量保存的生物工艺技术。

Bioprocess Technologies that Preserve the Quality of iPSCs.

机构信息

Department of Chemical Engineering, University of Massachusetts Lowell, Lowell, MA, USA.

Department of Chemical Engineering, University of Massachusetts Lowell, Lowell, MA, USA.

出版信息

Trends Biotechnol. 2020 Oct;38(10):1128-1140. doi: 10.1016/j.tibtech.2020.03.006. Epub 2020 Apr 5.

DOI:10.1016/j.tibtech.2020.03.006
PMID:32941792
Abstract

Large-scale production of induced pluripotent stem cells (iPSCs) is essential for the treatment of a variety of clinical indications. However, culturing enough iPSCs for clinical applications is problematic due to their sensitive pluripotent state and dependence on a supporting matrix. Developing stem cell bioprocessing strategies that are scalable and meet clinical needs requires incorporating methods that measure and monitor intrinsic markers of cell differentiation state, developmental status, and viability in real time. In addition, proper cell culture modalities that nurture the growth of high-quality stem cells in suspension are critical for industrial scale-up. In this review, we present an overview of cell culture media, suspension modalities, and monitoring techniques that preserve the quality and pluripotency of iPSCs during initiation, expansion, and manufacturing.

摘要

大规模生产诱导多能干细胞(iPSCs)对于治疗多种临床适应症至关重要。然而,由于 iPSCs 具有敏感的多能状态和对支持基质的依赖性,培养足够数量的 iPSCs 用于临床应用是有问题的。开发可扩展且满足临床需求的干细胞生物加工策略需要结合实时测量和监测细胞分化状态、发育状态和活力内在标志物的方法。此外,适当的细胞培养方式对于在悬浮状态下培养高质量干细胞的生长至关重要。在这篇综述中,我们介绍了细胞培养基、悬浮方式和监测技术,这些技术在 iPSCs 的起始、扩增和制造过程中保持了 iPSCs 的质量和多能性。

相似文献

1
Bioprocess Technologies that Preserve the Quality of iPSCs.iPSC 质量保存的生物工艺技术。
Trends Biotechnol. 2020 Oct;38(10):1128-1140. doi: 10.1016/j.tibtech.2020.03.006. Epub 2020 Apr 5.
2
Robust bioprocess design and evaluation of commercial media for the serial expansion of human induced pluripotent stem cell aggregate cultures in vertical-wheel bioreactors.在垂直轮生物反应器中对人诱导多能干细胞集落培养进行连续扩增的商业培养基的稳健生物工艺设计和评估。
Stem Cell Res Ther. 2024 Jul 29;15(1):232. doi: 10.1186/s13287-024-03819-9.
3
Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.搅拌悬浮生物反应器中诱导多能干细胞的扩增和长期维持。
J Tissue Eng Regen Med. 2012 Jun;6(6):462-72. doi: 10.1002/term.450. Epub 2011 Jul 14.
4
Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors.使用一次性生物反应器进行可扩展搅拌悬浮培养,以生成数十亿个人诱导多能干细胞。
J Tissue Eng Regen Med. 2018 Feb;12(2):e1076-e1087. doi: 10.1002/term.2435. Epub 2017 Oct 2.
5
Addressing bioreactor hiPSC aggregate stability, maintenance and scaleup challenges using a design of experiment approach.采用实验设计方法解决生物反应器 hiPSC 聚集体稳定性、维持和放大的挑战。
Stem Cell Res Ther. 2024 Jul 2;15(1):191. doi: 10.1186/s13287-024-03802-4.
6
Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred suspension bioreactors.克服垂直轮搅拌悬浮生物反应器中高质量人诱导多能干细胞聚集体大规模扩增过程中的生物工艺瓶颈。
Stem Cell Res Ther. 2021 Jan 13;12(1):55. doi: 10.1186/s13287-020-02109-4.
7
Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.喂养策略对一次性搅拌罐生物反应器中人类多能干细胞可扩展扩增的影响
Stem Cells Transl Med. 2016 Oct;5(10):1289-1301. doi: 10.5966/sctm.2015-0253. Epub 2016 Jul 1.
8
Scalable expansion of iPSC and their derivatives across multiple lineages.iPSC 及其衍生物在多个谱系中的可扩展扩增。
Reprod Toxicol. 2022 Sep;112:23-35. doi: 10.1016/j.reprotox.2022.05.007. Epub 2022 May 17.
9
Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor.在搅拌悬浮生物反应器中大规模生产大小可控的人类多能干细胞聚集体的生物工艺开发。
Tissue Eng Part C Methods. 2012 Nov;18(11):831-51. doi: 10.1089/ten.TEC.2012.0161. Epub 2012 Jun 13.
10
Expansion of 3D human induced pluripotent stem cell aggregates in bioreactors: Bioprocess intensification and scaling-up approaches.生物反应器中3D人诱导多能干细胞聚集体的扩增:生物过程强化与放大方法。
J Biotechnol. 2017 Mar 20;246:81-93. doi: 10.1016/j.jbiotec.2017.01.004. Epub 2017 Jan 25.

引用本文的文献

1
Functional Thyroid Organoids-Powerful Stem Cell-Derived Models in Basic and Translational Research.功能性甲状腺类器官——基础与转化研究中强大的干细胞衍生模型
Biomolecules. 2025 May 21;15(5):747. doi: 10.3390/biom15050747.
2
Anoikis in cell fate, physiopathology, and therapeutic interventions.细胞命运、生理病理学及治疗干预中的失巢凋亡
MedComm (2020). 2024 Sep 15;5(10):e718. doi: 10.1002/mco2.718. eCollection 2024 Oct.
3
Reprogramming stem cells in regenerative medicine.再生医学中的干细胞重编程。
Smart Med. 2022 Dec 25;1(1):e20220005. doi: 10.1002/SMMD.20220005. eCollection 2022 Dec.
4
Single-Use, Metabolite Absorbing, Resonant Transducer (SMART) Culture Vessels for Label-Free, Continuous Cell Culture Progression Monitoring.一次性使用、代谢物吸收、谐振式换能器(SMART)培养容器,用于无标记、连续的细胞培养过程监测。
Adv Sci (Weinh). 2024 Aug;11(32):e2401260. doi: 10.1002/advs.202401260. Epub 2024 Jun 20.
5
Manufacturing Parameters for the Creation of Clinical-Grade Human-Induced Pluripotent Stem Cell Lines From Umbilical Cord Mesenchymal Stromal Cells.从脐带间充质基质细胞中创建临床级人诱导多能干细胞系的制造参数。
Stem Cells Transl Med. 2024 May 14;13(5):454-461. doi: 10.1093/stcltm/szae010.
6
Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.探索诱导多能干细胞在癌症研究和治疗中的广阔前景。
Mol Cancer. 2023 Nov 28;22(1):189. doi: 10.1186/s12943-023-01873-0.
7
The cellular model for Alzheimer's disease research: PC12 cells.用于阿尔茨海默病研究的细胞模型:嗜铬细胞瘤细胞(PC12细胞)
Front Mol Neurosci. 2023 Jan 4;15:1016559. doi: 10.3389/fnmol.2022.1016559. eCollection 2022.
8
Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design.在质量源于设计的框架下对人诱导多能干细胞生物反应器中 cGMP 大规模扩增工艺的批判性分析。
BioDrugs. 2021 Nov;35(6):693-714. doi: 10.1007/s40259-021-00503-9. Epub 2021 Nov 2.
9
Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic.干细胞扩增生物工艺开发、优化及制造背景下的诱导多能性:通往临床的路线图。
NPJ Regen Med. 2021 Nov 1;6(1):72. doi: 10.1038/s41536-021-00183-7.
10
Identification of novel inhibitory metabolites and impact verification on growth and protein synthesis in mammalian cells.新型抑制性代谢物的鉴定及其对哺乳动物细胞生长和蛋白质合成的影响验证
Metab Eng Commun. 2021 Sep 6;13:e00182. doi: 10.1016/j.mec.2021.e00182. eCollection 2021 Dec.